(VIANEWS) – UCB (UCB.BR), DOCK.PETR.AMBES AM (DPAM.PA), AXA (CS.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 45.93. Meaning, the purchaser of the share is investing €45.93 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Yearly Top and Bottom Value
UCB’s stock is valued at €78.08 at 07:10 EST, way below its 52-week high of €88.80 and way above its 52-week low of €69.56.
Moving Average
UCB’s value is under its 50-day moving average of €81.49 and under its 200-day moving average of €80.98.
More news about UCB.
2. DOCK.PETR.AMBES AM (DPAM.PA)
76.33% Payout Ratio
Les Docks des Pétroles d'Ambès -SA engages in the storage and shipping of petroleum products in France. It stores and distributes species, diesel, and combustibles, as well as bio, jet, technical, and marine fuel products. The company was founded in 1930 and is based in Carbon-Blanc, France.
Earnings Per Share
As for profitability, DOCK.PETR.AMBES AM has a trailing twelve months EPS of €43.21.
PE Ratio
DOCK.PETR.AMBES AM has a trailing twelve months price to earnings ratio of 11.2. Meaning, the purchaser of the share is investing €11.2 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.74%.
More news about DOCK.PETR.AMBES AM.
3. AXA (CS.PA)
50.66% Payout Ratio
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France, Europe, Asia, AXA XL, International, and Transversal & Central Holdings. It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products. The company also provides property and casualty insurance products, including car, home, and personal or professional liability to individual and business clients; international insurance for large corporate clients in Europe; and marine and aviation insurance services, as well as property and casualty reinsurance products. In addition, it offers asset management services in the areas of various asset classes, including equities, bonds, hedge funds, private equity, and real estate for the group's insurance companies and their clients, and retail and institutional clients. Further, the company provides health, term life, whole life, universal life, endowment, and other investment-based products for personal/individual and commercial/ group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, AXA has a trailing twelve months EPS of €2.88.
PE Ratio
AXA has a trailing twelve months price to earnings ratio of 9.68. Meaning, the purchaser of the share is investing €9.68 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.69%.
Volume
Today’s last reported volume for AXA is 1153570 which is 61.71% below its average volume of 3013280.
Revenue Growth
Year-on-year quarterly revenue growth declined by 23.7%, now sitting on 107.73B for the twelve trailing months.
Yearly Top and Bottom Value
AXA’s stock is valued at €27.86 at 07:10 EST, under its 52-week high of €28.95 and way higher than its 52-week low of €20.33.
More news about AXA.
4. BOIRON (BOI.PA)
40.15% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.89.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 18.3. Meaning, the purchaser of the share is investing €18.3 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.
More news about BOIRON.
5. HYDRATEC (HYDRA.AS)
37.84% Payout Ratio
Hydratec Industries NV, through its subsidiaries, engages in the manufacture and sale of industrial systems and plastic components for food, health, and mobility markets in the Netherlands, rest of Europe, Asia, North America, South America, Africa, and Oceania. It develops and produces sterilized product handling systems; and automated packaging solutions, including packaging for sterilized food in pouches, tins, and jars, as well as main-meal salads and agri-food in bags, nets, boxes, and crates. The company also supplies industrial incubators to produce day-old chicks; hatchery automation systems for processing of hatchery eggs and day-old chicks; climate control equipment for air and water treatment; hatchery management software for monitoring, analyzing, and optimizing the hatching process; and service and support for hatchery systems operation. In addition, it manufactures extrusion machines for PVC, PVC-O, and PO pipes; plastic injection molding products for use in climate control systems, lorries, bicycle parts, and coffee machines; rubber and plastic precision components for fuel systems, braking and drive systems, dosing systems for beer, coffee and milk, medical cartridges, point-of-care instruments, and diagnosis equipment. Hydratec Industries NV is headquartered in Amersfoort, the Netherlands.
Earnings Per Share
As for profitability, HYDRATEC has a trailing twelve months EPS of €11.85.
PE Ratio
HYDRATEC has a trailing twelve months price to earnings ratio of 7.22. Meaning, the purchaser of the share is investing €7.22 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.49%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 19, 2023, the estimated forward annual dividend rate is 6 and the estimated forward annual dividend yield is 6.98%.
Yearly Top and Bottom Value
HYDRATEC’s stock is valued at €85.50 at 07:10 EST, below its 52-week high of €92.50 and way higher than its 52-week low of €68.00.
Moving Average
HYDRATEC’s worth is below its 50-day moving average of €86.72 and above its 200-day moving average of €81.06.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 283.26M for the twelve trailing months.
More news about HYDRATEC.
6. CAPGEMINI (CAP.PA)
34.03% Payout Ratio
Capgemini SE provides consulting, digital transformation, technology, and engineering services primarily in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers strategy and transformation services, including strategy, technology, data science, and creative design to support various clients within the digital economy. It also provides applications and technology services that helps the clients to develop, modernize, extend, and secure their IT and digital environment using the latest technologies, as well as offers local technology services in cloud, cybersecurity, quality assurance, testing, and new technology fields. In addition, the company offers business process outsourcing and transactional services, as well as installation and maintenance services for its clients' IT infrastructures in data centers or in the cloud. It serves various industries, including consumer goods and retail; energy and utilities; banking, capital markets, and insurance; manufacturing and life sciences; public sector; telecommunications, media, and technology; and services. Capgemini SE has strategic partnerships with CONA Services LLC to develop digital solutions for the consumer products industry and retail customers; and Innoveo Inc. to deliver digital transformation solutions to insurance clients across various lines of business. The company was founded in 1967 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, CAPGEMINI has a trailing twelve months EPS of €9.56.
PE Ratio
CAPGEMINI has a trailing twelve months price to earnings ratio of 17.23. Meaning, the purchaser of the share is investing €17.23 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.8%.
Yearly Top and Bottom Value
CAPGEMINI’s stock is valued at €164.75 at 07:10 EST, way below its 52-week high of €189.75 and above its 52-week low of €152.25.
More news about CAPGEMINI.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Sales Growth
1’s sales growth is 1% for the ongoing quarter and 1% for the next.
More news about 1.
